JOVANA
Explore Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Does It Work? Evidence, Limits, and the Open Frontier

The capstone reckoning: what the evidence really supports, the gap between measurable plasticity and meaningful recovery, and what would actually move the field.

The evidence problem

Here is the honest state of the field. Physiology-level plasticity induction — changed motor-evoked potentials, altered connectivity — is real and repeatable. Its translation into durable, meaningful daily-life function is promising but not established. Meta-analyses favor BCI-based rehabilitation over control for upper-limb stroke, yet with small samples, heterogeneous protocols, short follow-up, and low-to-moderate evidence quality — the recurring caveats around outcome measures and clinical outcomes.

The plasticity-versus-recovery gap

A changed motor-evoked potential is not a restored hand. Physiological markers and functional outcomes correlate only weakly, and we still lack a validated biomarker that predicts who will recover. The therapeutic dose — how much, how often, for how long — is essentially unknown; there is no established dose-response curve for a rehab BCI.

The stability-plasticity dilemma bites here too: you want to open plasticity enough to relearn, without destabilizing already-consolidated circuits or amplifying the maladaptive patterns of Guide 4. Too little plasticity and nothing changes; too much and you risk erasing what still works.

What would move the field

Five levers, honestly assessed. One: responder biomarkers, to target the right patients in the right states. Two: precise, low-latency closed loops that reliably hit the plasticity window. Three: larger, better-blinded, longer randomized trials with function-level endpoints, not just physiology. Four: mechanistic clarity on which pairing rule matters for which deficit. Five: combination therapy — a rehab BCI plus an approved plasticity enhancer, critical-period reopening, or paired VNS.

An honest outlook

The strong claim — 'BCIs will heal the injured brain' — is neither proven nor absurd. The mechanism is genuine, the engineering of timing, contingency and personalization is tractable, and the clinical evidence is early. Expect incremental, indication-specific gains — stroke upper limb, spinal-cord-injury locomotion — rather than a general cure. And judge every claim you meet by a single test: did it isolate plasticity from exercise and expectation?